Psychiatrist Philip G. Janicak, MD has joined Linden Oaks as Director of the new Transcranial Magnetic Stimulation (TMS) Center. TMS is primarily used to treat patients with treatment-resistant major depression, a disorder in which traditional medications are not effective or tolerated. The procedure uses a targeted, pulsed magnetic field, similar in intensity to an MRI device, to stimulate nerve cells in the area of the brain responsible for mood control and depression.